News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
283,715 Results
Type
Article (22931)
Company Profile (49)
Press Release (260735)
Section
Business (76191)
Career Advice (724)
Deals (11444)
Drug Delivery (47)
Drug Development (39679)
Employer Resources (69)
FDA (6987)
Job Trends (6484)
News (134313)
Policy (12479)
Tag
2024 BioCapital Digital (4)
2024 BioForest Digital (2)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (5)
2024 Biotech Beach Digital (1)
2024 Genetown Digital (1)
2024 Genetown Standard (2)
2024 Lone Star Bio Digital (3)
2024 Pharm Country Standard (2)
Academia (2141)
Accelerated approval (3)
Adcomms (17)
Allergies (40)
Alliances (23145)
ALS (62)
Alzheimer's disease (1066)
Antibody-drug conjugate (ADC) (54)
Approvals (6971)
Artificial intelligence (148)
Autoimmune disease (6)
Automation (7)
Bankruptcy (119)
Best Places to Work (5715)
BIOSECURE Act (14)
Biosimilars (29)
Biotechnology (37)
Bladder cancer (34)
Brain cancer (17)
Breast cancer (153)
Cancer (1228)
Cardiovascular disease (90)
Career advice (628)
Career pathing (15)
CAR-T (69)
Cell therapy (207)
Cervical cancer (15)
Clinical research (31393)
Collaboration (455)
Compensation (61)
Complete response letters (11)
COVID-19 (1668)
CRISPR (21)
C-suite (119)
Cystic fibrosis (55)
Data (1193)
Decentralized trials (1)
Denatured (3)
Depression (21)
Diabetes (112)
Diagnostics (3803)
Digital health (6)
Diversity (3)
Diversity, equity & inclusion (23)
Drug discovery (61)
Drug pricing (45)
Drug shortages (6)
Duchenne muscular dystrophy (50)
Earnings (22202)
Editorial (21)
Employer branding (6)
Employer resources (62)
Events (38194)
Executive appointments (339)
FDA (7648)
Featured Employer (13)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (6)
Funding (445)
Gene editing (50)
Generative AI (11)
Gene therapy (192)
GLP-1 (273)
Government (2336)
Grass and pollen (1)
Guidances (20)
Healthcare (9158)
Huntington's disease (14)
IgA nephropathy (19)
Immunology and inflammation (63)
Indications (14)
Infectious disease (1746)
Inflammatory bowel disease (80)
Inflation Reduction Act (4)
Influenza (29)
Intellectual property (50)
Interviews (104)
IPO (5421)
IRA (22)
Job creations (994)
Job search strategy (556)
Kidney cancer (6)
Labor market (9)
Layoffs (142)
Leadership (6)
Legal (1864)
Liver cancer (37)
Lung cancer (190)
Lymphoma (83)
Machine learning (4)
Management (24)
Manufacturing (131)
MASH (30)
Medical device (5249)
Medtech (5252)
Mergers & acquisitions (6247)
Metabolic disorders (284)
Multiple sclerosis (46)
NASH (8)
Neurodegenerative disease (58)
Neuropsychiatric disorders (9)
Neuroscience (1377)
NextGen: Class of 2025 (2995)
Non-profit (3068)
Northern California (1129)
Now hiring (6)
Obesity (138)
Opinion (129)
Ovarian cancer (39)
Pain (47)
Pancreatic cancer (32)
Parkinson's disease (87)
Partnered (9)
Patents (97)
Patient recruitment (58)
Peanut (23)
People (26317)
Pharmaceutical (17)
Pharmacy benefit managers (4)
Phase I (10290)
Phase II (14365)
Phase III (9993)
Pipeline (582)
Podcasts (10)
Policy (70)
Postmarket research (917)
Preclinical (4661)
Press Release (36)
Prostate cancer (61)
Psychedelics (27)
Radiopharmaceuticals (110)
Rare diseases (222)
Real estate (2097)
Recruiting (26)
Regulatory (9351)
Reports (21)
Research institute (2106)
Resumes & cover letters (92)
Rett syndrome (3)
RNA editing (3)
RSV (12)
Schizophrenia (41)
Series A (70)
Series B (40)
Service/supplier (1)
Sickle cell disease (37)
Southern California (1000)
Special edition (3)
Spinal muscular atrophy (100)
Sponsored (23)
Startups (1732)
Stomach cancer (7)
Supply chain (20)
The Weekly (6)
United States (10456)
Vaccines (358)
Venture capitalists (15)
Webinars (8)
Weight loss (74)
Women's health (9)
Worklife (6)
Date
Today (144)
Last 7 days (403)
Last 30 days (1479)
Last 365 days (17053)
2025 (4189)
2024 (17497)
2023 (19697)
2022 (24537)
2021 (27152)
2020 (26274)
2019 (21551)
2018 (16025)
2017 (14303)
2016 (13532)
2015 (15566)
2014 (11120)
2013 (9091)
2012 (9441)
2011 (9667)
2010 (8115)
Location
Africa (332)
Alabama (39)
Alaska (3)
Arizona (83)
Arkansas (6)
Asia (16213)
Australia (3409)
California (2626)
Canada (777)
China (214)
Colorado (119)
Connecticut (113)
Delaware (66)
Europe (36704)
Florida (434)
Georgia (78)
Idaho (26)
Illinois (251)
India (11)
Indiana (124)
Iowa (3)
Japan (74)
Kansas (48)
Kentucky (14)
Louisiana (6)
Maine (24)
Maryland (389)
Massachusetts (2017)
Michigan (79)
Minnesota (132)
Mississippi (1)
Missouri (43)
Montana (14)
Nebraska (13)
Nevada (19)
New Hampshire (33)
New Jersey (861)
New Mexico (21)
New York (886)
North Carolina (409)
North Dakota (6)
Northern California (1129)
Ohio (117)
Oklahoma (11)
Oregon (17)
Pennsylvania (601)
Puerto Rico (2)
Rhode Island (12)
South America (419)
South Carolina (7)
Southern California (1000)
Tennessee (56)
Texas (496)
Utah (100)
Virginia (67)
Washington D.C. (40)
Washington State (227)
West Virginia (2)
Wisconsin (27)
283,715 Results for "critical path institute".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
BioMidwest
C-Path and CENTOGENE MOU to Enhance Collaboration in Lysosomal Disease Research and Drug Development
Critical Path Institute and Centogene N.V. are pleased to announce the signing of a Memorandum of Understanding to advance drug development for lysosomal diseases and improve the quality of life for those impacted by these conditions.
June 20, 2024
·
5 min read
Press Releases
Bio-Path Holdings Reports Full Year 2024 Financial Results
March 31, 2025
·
7 min read
C-Path Launches Clinical Trial Simulator for Duchenne Muscular Dystrophy Research
Critical Path Institute’s (C-Path) Duchenne Regulatory Science Consortium (D-RSC) is excited to announce the launch of a groundbreaking model-based Clinical Trial Simulator (CTS), specifically designed to improve design of efficacy studies for potential therapies for Duchenne muscular dystrophy (DMD).
March 28, 2024
·
4 min read
Press Releases
Etiometry Launches ADK 2.0 to Support Critical Care Researchers with a Quick Path to Design and Deploy Custom Algorithms to Translate Outcomes Data into Practice
December 12, 2024
·
3 min read
Business
C-Path Appoints Dr. Klaus Romero as New CEO
Critical Path Institute announced that Klaus Romero, M.D., M.S., FCP, has been named its new Chief Executive Officer.
January 9, 2024
·
4 min read
Press Releases
Cutting-edge Recommendations Provide Treatment Path for Millions of Long COVID Patients
February 12, 2025
·
3 min read
Press Releases
Bio-Path Holdings Expands Global Patent Portfolio
February 14, 2025
·
4 min read
Press Releases
Bio-Path Holdings Provides Key Clinical Updates
February 14, 2025
·
6 min read
Alzheimer’s disease
EU Rejects Lilly’s Alzheimer’s Drug Kisunla, Following Same Path as Rival Leqembi
The European Union’s CHMP said that the benefits of the drug, already approved in the U.S., do not outweigh the risk of potentially fatal brain swelling and bleeding.
March 28, 2025
·
2 min read
·
Dan Samorodnitsky
Press Releases
Colossal Creates the Colossal Woolly Mouse, Showcasing Breakthroughs in Multiplex Genome Editing and Trait Engineering on the Path to a Mammoth
March 5, 2025
·
6 min read
1 of 28,372
Next
